ADHD in the News 2023-06-15

What is ADHD in adults? A doctor answers

Akron Beacon Journal's Betty Lin-Fisher and University Hospitals Rainbow Babies and Children's Hospital Dr. Max Wiznitzer talk about ADHD in adults.

ADHD in Children: Focus on the Positives

Jami Demuth is the mother of three children in their teens, all of whom have attention deficit hyperactivity disorder (ADHD). Her parenting strategy? She encourages them to find ways to use their ADHD symptoms to their advantage.

ADHD: inattention and hyperactivity have been the focus of research – but emotional problems may be the missing link

So what is the neural link between ADHD and emotions? In our new study, published in Nature Medicine with colleagues at Fudan University in China, we identified a general brain basis – that we call the Neuropsychopathological Factor (NP Factor) – underlying symptoms of multiple mental health disorders, from depression to ADHD.

About 15% of US children recently received mental health treatment, new CDC data shows

(CNN) - Nearly 15% of children in the United States were recently treated for mental health disorders in 2021, according to new research from the US Centers for Disease Control and Prevention.

People who use ‘smart drugs’ worse at complex tasks, study finds

Research has found those who use medications such as Ritalin without having conditions such as ADHD actually reduce their mental performance

Manufacturing delays hit Takeda’s Vyvanse amid ADHD drug shortage

Takeda Pharmaceutical Company Limited is facing a manufacturing delay for its ADHD drug, Vyvanse, just as shortages for other ADHD drugs roil the country.

Senators propose ‘first step’ to address US drug shortages by examining supply chains

The deficits are a "serious national security risk and could compromise" care.

Investigating the Long-Term Safety of ADHD Medication for Children and Adolescents

[Excerpt] Now, a recent study from the Attention Deficit Hyperactivity Drugs Use Chronic Effects (ADDUCE) project, published in The Lancet, aimed to address these concerns by investigating the safety of methylphenidate in children and adolescents over a 2-year period. Technology Networks spoke with Dr. Sarah Inglis, trial manager for the ADDUCE study, to learn more about its findings and potential implications.

Mixed Bag Phase 3 Data for ADHD Treatment Presented at ASHP Meeting

CONFERENCE REPORTER: Researchers shared mixed good news for the novel treatment centanafadine for treating attention-deficit/hyperactivity disorder at the American Society of Health-System Pharmacists 2023 Summer Meetings and Exhibition.1 Specifically, they found centanafadine had a better safety profile and demonstrated more favorable tolerability but was less effective than lisdexamfetamine dimesylate (Vyvanse) for adults with ADHD.

New computerized training approach found to significantly reduce ADHD symptoms in 1 in 3 participants

Computerized Progressive Attention Training (CPAT), a new treatment developed at Tel Aviv University, significantly improved the symptoms of 33 percent of students suffering from Attention Deficit Hyperactivity Disorder (ADHD).

Attention Deficits are Not Just for Kids: Experiencing ADHD as an Adult

ADHD is a common mental disorder among children and adolescents. But often symptoms continue into adulthood, where it is underdiagnosed and undertreated. A late-stage diagnosis can be life-changing.

Your child is neurodivergent. Should you tell everyone?

Pavel Tabutov’s family had been invited to a gathering near his Los Angeles exurb home to hear a friend’s daughter perform with her singing group. But it wasn’t a great night to go out. His three young kids were cranky, and it would be a crowded social event where the kids would need to sit still during a performance.